GPT and neuromuscular disease: Our investigations demonstrate thetherapeutic potential of ALT-007 to mitigate age-related muscle lossand fitness decline potentially by reducing the levels of deoxy-sphingolipidsof very-long chains and their impact on cellular protein homeostasis.Our findings highlight ALT-007 as a safe and orally bioavailable compoundwith potential to mitigate neuromuscular diseases.